NICE guidance on pixantrone monotherapy for multiply relapsed or refractory aggressive non-Hodgkin lymphoma

Linda J Landells, Carl Prescott, Nicola Hay, Frances Sutcliffe, Andrew Stevens

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)381-382
Number of pages2
JournalThe Lancet Oncology
Volume15
Issue number4
Early online date26 Feb 2014
DOIs
Publication statusPublished - Apr 2014

Keywords

  • Cost-Benefit Analysis
  • Drug Approval
  • Drug Costs
  • Drug Resistance, Neoplasm
  • Evidence-Based Medicine
  • Humans
  • Isoquinolines
  • Lymphoma, Non-Hodgkin
  • Practice Guidelines as Topic
  • Recurrence
  • Topoisomerase II Inhibitors
  • Treatment Outcome

Cite this